NAP
SEM

New Amsterdam Partners’s Select Medical SEM Stock Holding History

New Amsterdam Partners’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-215,292
Closed -$1.54M – 143
2016
Q4 		$1.54M Sell
215,292
-955,022
-82% -$6.65M 0.35% 85
2016
Q3 		$8.51M Buy
1,170,314
+480,572
+70% +$3.05M 1.96% 11
2016
Q2 		$4.04M Buy
+689,742
New +$4.57M 0.98% 48
2016
Q1 		– Sell
-534,589
Closed -$3.43M – 143
2015
Q4 		$3.43M Sell
534,589
-730
-0.1% -$4.56K 0.35% 70
2015
Q3 		$3.11M Buy
+535,319
New +$3.97M 0.32% 71

Other funds holding SEM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

New Amsterdam Partners's SEM Position: Q1 2017 in Review

New Amsterdam Partners sold out of Select Medical (SEM) in Q1 2017, closing a stake of 215,292 shares — an estimated $1.54M sold.

New Amsterdam Partners first reported a position in SEM in Q3 2015 and held it in 5 quarters. The position peaked at $8.51M in Q3 2016. 164 funds tracked by Wall St. Rank hold SEM as of Q1 2017.

  • New Amsterdam Partners reported no remaining Select Medical position as of Q1 2017 after selling out during the quarter.
  • New Amsterdam Partners sold 215,292 Select Medical shares in Q1 2017, an estimated $1.54M.
  • New Amsterdam Partners first reported a position in Select Medical in Q3 2015 and held it in 5 quarters.
  • New Amsterdam Partners's Select Medical position peaked at $8.51M in Q3 2016.
  • 164 funds tracked by Wall St. Rank held Select Medical as of Q1 2017.

Based on New Amsterdam Partners's 13F filing for Q1 2017, filed 3 May 2017.